3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
102
Neoplasms, Plasma Cell
12
Recurrence
9
Lymphoma
8
Immunoglobulin Light-chain Amyloidosis
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Neoplasms
5
Leukemia, Myeloid, Acute
5
Lymphoma, Mantle-Cell
4
Waldenstrom Macroglobulinemia
3
Paraproteinemias
3
Hematologic Neoplasms
3
Amyloidosis
3
Renal Insufficiency
2
Myelodysplastic Syndromes
2
Lymphoproliferative Disorders
2
Lymphoma, T-Cell
2
Burkitt Lymphoma
2
beta-Thalassemia
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Thalassemia
1
Sarcoma, Myeloid
1
Prostatic Neoplasms
1
Plasmacytoma
1
Plasmablastic Lymphoma
1
Peripheral Nervous System Diseases
1
Interventions
Paclitaxel
4
Cyclophosphamide
4
exemestane
3
Taxes
3
Tamoxifen
3
Letrozole
3
Doxorubicin
3
Anastrozole
3
Trastuzumab
2
Leuprolide
2
Immunotherapy
2
Goserelin
2
Carboplatin
2
trastuzumab biosimilar HLX02
1
ribociclib
1
pegfilgrastim
1
elacestrant
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
abemaciclib
1
Vitamins
1
Standard of Care
1
Radiosurgery
1
Psychiatric Rehabilitation
1
Practice Guidelines as Topic
1
PF-05280014
1
Ontruzant
1
Omeprazole
1
Ogivri
1
Neoadjuvant Therapy
1
Methods
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Breast Neoplasms, Male
×
Bortezomib
×
1 year
×
Clear all
No trials found.